Health Canada approves cannabis-derived pain drug CTV.ca Wed, 08 Aug 2007 5:48 AM PDT A cannabis-derived drug that's been on the market for two years in Canada to relieve pain in multiple sclerosis patients is now approved for use by certain patients with cancer.

Health and science news from UC campuses and labs UC Newswire Wed, 08 Aug 2007 10:44 AM PDT Researchers uncover new pathway for popular MS drug Aug 06, UCSF -- Researchers at UCSF and Stanford University have discovered a key mechanism responsible for the activity of a commonly prescribed drug for treating multiple sclerosis (MS), which they hope will spur better therapies for the disease.

Marijuana-derived drug approved for cancer pain
CBC Tue, 07 Aug 2007 2:57 PM PDT
Sativex, a marijuana-derived mouth spray already used to treat pain in patients with multiple sclerosis, has been approved by Health Canada for patients with advanced cancer.